Gradient Investments’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
AI
FA
II
CFD
OWM
CW
BFS
PFG
Gradient Investments's IBD Position: Q3 2024 in Review
Gradient Investments sold out of Inspire Corporate Bond ETF (IBD) in Q3 2024, closing a stake of 7,922 shares — an estimated $185K sold.
Gradient Investments first reported a position in IBD in Q4 2022 and held it in 7 quarters. The position peaked at $188K in Q4 2023. 80 funds tracked by Wall St. Rank hold IBD as of Q3 2024.
- Gradient Investments reported no remaining Inspire Corporate Bond ETF position as of Q3 2024 after selling out during the quarter.
- Gradient Investments sold 7,922 Inspire Corporate Bond ETF shares in Q3 2024, an estimated $185K.
- Gradient Investments first reported a position in Inspire Corporate Bond ETF in Q4 2022 and held it in 7 quarters.
- Gradient Investments's Inspire Corporate Bond ETF position peaked at $188K in Q4 2023.
- 80 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q3 2024.
Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.